Cerus Corp. (CERS)
2.285
-0.06
(-2.35%)
USD |
NASDAQ |
Oct 07, 16:00
2.285
0.00 (0.00%)
After-Hours: 17:12
Cerus Net Income (Quarterly) : -2.982M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.982M |
| March 31, 2026 | -1.648M |
| December 31, 2025 | -2.184M |
| September 30, 2025 | -0.02M |
| June 30, 2025 | -5.715M |
| March 31, 2025 | -7.718M |
| December 31, 2024 | -2.562M |
| September 30, 2024 | -2.934M |
| June 30, 2024 | -5.775M |
| March 31, 2024 | -9.69M |
| December 31, 2023 | -1.389M |
| September 30, 2023 | -7.286M |
| June 30, 2023 | -13.33M |
| March 31, 2023 | -15.64M |
| December 31, 2022 | -13.62M |
| September 30, 2022 | -8.521M |
| June 30, 2022 | -8.395M |
| March 31, 2022 | -12.28M |
| December 31, 2021 | -9.121M |
| September 30, 2021 | -12.44M |
| June 30, 2021 | -15.36M |
| March 31, 2021 | -17.46M |
| December 31, 2020 | -14.38M |
| September 30, 2020 | -14.14M |
| June 30, 2020 | -14.87M |
| Date | Value |
|---|---|
| March 31, 2020 | -16.47M |
| December 31, 2019 | -16.92M |
| September 30, 2019 | -17.97M |
| June 30, 2019 | -17.56M |
| March 31, 2019 | -18.79M |
| December 31, 2018 | -16.20M |
| September 30, 2018 | -14.19M |
| June 30, 2018 | -13.28M |
| March 31, 2018 | -13.88M |
| December 31, 2017 | -11.49M |
| September 30, 2017 | -13.42M |
| June 30, 2017 | -17.08M |
| March 31, 2017 | -18.60M |
| December 31, 2016 | -13.50M |
| September 30, 2016 | -14.38M |
| June 30, 2016 | -18.17M |
| March 31, 2016 | -16.86M |
| December 31, 2015 | -14.76M |
| September 30, 2015 | -15.68M |
| June 30, 2015 | -15.97M |
| March 31, 2015 | -9.46M |
| December 31, 2014 | -20.18M |
| September 30, 2014 | -10.76M |
| June 30, 2014 | -7.589M |
| March 31, 2014 | -0.225M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| DexCom, Inc. | 249.10M |
| Abbott Laboratories | 928.00M |
| AngioDynamics, Inc. | -11.40M |
| Alphatec Holdings, Inc. | -25.78M |
| AtriCure, Inc. | 8.955M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 57.44M |
| Total Expenses (Quarterly) | 60.38M |
| EPS Diluted (Quarterly) | -0.0147 |
| Enterprise Value | 492.64M |
| Gross Profit Margin (Quarterly) | 50.61% |
| Profit Margin (Quarterly) | -5.19% |
| Earnings Yield | -1.51% |
| Normalized Earnings Yield | -1.514 |